Fig. 1From: Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trialTrial Schema. * Nodal disease (N1/M1a) identified on a Prostate-specific membrane antigen (PSMA) PET/CT scanBack to article page